EARLY EFFECTS OF SACUBITRIL/VALSARTAN ON CARDIAC FUNCTION AND CARDIOPULMONARY PERFORMANCE OF PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION. AVIRTUOUS CIRCLE?

被引：0
|
作者：
Romano, G.
Vitale, G.
Raffa, G.
Aiello, L.
Sarullo, F.
Clemenza, F.
机构：
[1] IRCCS ISMETT, Palermo, Italy
[2] Osped Buccheri La Ferla, Palermo, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2019年 / 21卷 / 0E期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C87
引用
收藏
页码：E49 / E49
页数：1
相关论文
共 50 条
  • [21] Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction
    Giovanni Battista Bolla
    Antonella Fedele
    Andrea Faggiano
    Carla Sala
    Gloria Santangelo
    Stefano Carugo
    BMC Cardiovascular Disorders, 22
  • [22] Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Pericas, Pere
    Mas-Llado, Caterina
    Ramis-Barcelo, Maria Francisca
    Valadron, Isabel
    Noris Mora, Marta
    Pasamar Marquez, Lucia
    Gonzalez Colino, Rosa
    Forteza Alberti, Jose Francisco
    Peral Disdier, Vicente
    Rossello, Xavier
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 167 - 175
  • [23] Effects of sacubitril/valsartan on renal function and outcome in patients with heart failure and reduced ejection fraction: an Italian cohort study
    Palazzuoli, Alberto
    Pirrotta, Filippo
    Cartocci, Alessandra
    Delcuratolo, Elvira
    Dini, Frank Loyd
    Correale, Michele
    Dattilo, Giuseppe
    Masarone, Daniele
    Scelsi, Laura
    Ghio, Stefano
    Tocchetti, Carlo Gabriele
    Mercurio, Valentina
    Brunetti, Natale Daniele
    Nodari, Savina
    Barilla, Francesco
    Ambrosio, Giuseppe
    Carluccio, Erberto
    THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2024, 18
  • [24] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    McCormack, Paul L.
    DRUGS, 2016, 76 (03) : 387 - 396
  • [25] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    Paul L. McCormack
    Drugs, 2016, 76 : 387 - 396
  • [26] Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
    Pascual-Figal, Domingo
    Bayes-Genis, Antoni
    Beltran-Troncoso, Paola
    Caravaca-Perez, Pedro
    Conde-Martel, Alicia
    Crespo-Leiro, Maria G.
    Delgado, Juan F.
    Diez, Javier
    Formiga, Francesc
    Manito, Nicolas
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [27] Sacubitril/Valsartan Improves Left Ventricular Ejection Fraction and Reverses Cardiac Remodeling in Taiwanese Patients with Heart Failure and Reduced Ejection Fraction
    Liu, Li-Wei
    Wu, Po-Ching
    Chiu, Mei-Ya
    Tu, Pei-Fen
    Fang, Ching-Chang
    ACTA CARDIOLOGICA SINICA, 2020, 36 (02) : 125 - 132
  • [28] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [29] Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan
    Diez-Villanueva, Pablo
    Vicent, Lourdes
    de la Cuerda, Francisco
    Esteban-Fernandez, Alberto
    Gomez-Bueno, Manuel
    de Juan-Baguda, Javier
    Manuel Iniesta, Angel
    Ayesta, Ana
    Rojas-Gonzalez, Antonio
    Bover-Freire, Ramon
    Iglesias, Diego
    Garcia-Aguado, Marcos
    Angel Perea-Egido, Jesus
    Salamanca, Jorge
    Martinez-Selles, Manuel
    CARDIOLOGY, 2020, 145 (05) : 275 - 282
  • [30] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Hasan Ali Barman
    Selim Tanyolaç
    Omer Dogan
    Erdem Bal
    Adem Atıcı
    Serhan Özyıldırım
    Zerrin Yiğit
    Clinical Drug Investigation, 2022, 42 : 533 - 540
12345